| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | retinoic acid 4-hydroxylase activity | 1.13e-07 | 14 | 67 | 4 | GO:0008401 | |
| GeneOntologyMolecularFunction | linoleic acid epoxygenase activity | 1.44e-07 | 4 | 67 | 3 | GO:0071614 | |
| GeneOntologyMolecularFunction | arachidonate epoxygenase activity | 1.17e-06 | 24 | 67 | 4 | GO:0008392 | |
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity | 1.25e-06 | 7 | 67 | 3 | GO:0008467 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 1.92e-06 | 27 | 67 | 4 | GO:0008391 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | 2.00e-06 | 8 | 67 | 3 | GO:0033695 | |
| GeneOntologyMolecularFunction | caffeine oxidase activity | 2.00e-06 | 8 | 67 | 3 | GO:0034875 | |
| GeneOntologyMolecularFunction | aromatase activity | 5.60e-06 | 35 | 67 | 4 | GO:0070330 | |
| GeneOntologyMolecularFunction | estrogen 16-alpha-hydroxylase activity | 5.84e-06 | 11 | 67 | 3 | GO:0101020 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 7.84e-06 | 38 | 67 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | (R)-limonene 6-monooxygenase activity | 1.11e-05 | 2 | 67 | 2 | GO:0052741 | |
| GeneOntologyMolecularFunction | limonene monooxygenase activity | 1.11e-05 | 2 | 67 | 2 | GO:0019113 | |
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine 3-sulfotransferase 3 activity | 1.11e-05 | 2 | 67 | 2 | GO:0033872 | |
| GeneOntologyMolecularFunction | (S)-limonene 6-monooxygenase activity | 1.11e-05 | 2 | 67 | 2 | GO:0018675 | |
| GeneOntologyMolecularFunction | (S)-limonene 7-monooxygenase activity | 1.11e-05 | 2 | 67 | 2 | GO:0018676 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups | 1.60e-05 | 15 | 67 | 3 | GO:0016725 | |
| GeneOntologyMolecularFunction | heparan sulfate sulfotransferase activity | 1.60e-05 | 15 | 67 | 3 | GO:0034483 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 2.19e-05 | 49 | 67 | 4 | GO:0016712 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 4.77e-05 | 118 | 67 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | arachidonate 11,12-epoxygenase activity | 6.63e-05 | 4 | 67 | 2 | GO:0008405 | |
| GeneOntologyMolecularFunction | fatty acid omega-1 hydroxylase activity | 1.10e-04 | 5 | 67 | 2 | GO:0120502 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-1 hydroxylase activity | 1.10e-04 | 5 | 67 | 2 | GO:0120319 | |
| GeneOntologyMolecularFunction | arachidonate 14,15-epoxygenase activity | 1.10e-04 | 5 | 67 | 2 | GO:0008404 | |
| GeneOntologyMolecularFunction | steroid hydroxylase activity | 2.01e-04 | 34 | 67 | 3 | GO:0008395 | |
| GeneOntologyMolecularFunction | calcium-dependent protein binding | 3.30e-04 | 98 | 67 | 4 | GO:0048306 | |
| GeneOntologyMolecularFunction | monooxygenase activity | 6.05e-04 | 115 | 67 | 4 | GO:0004497 | |
| GeneOntologyMolecularFunction | sulfotransferase activity | 8.36e-04 | 55 | 67 | 3 | GO:0008146 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.05e-03 | 230 | 67 | 5 | GO:0005516 | |
| GeneOntologyMolecularFunction | heme binding | 1.79e-03 | 154 | 67 | 4 | GO:0020037 | |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | 1.97e-03 | 74 | 67 | 3 | GO:0016782 | |
| GeneOntologyMolecularFunction | tetrapyrrole binding | 2.25e-03 | 164 | 67 | 4 | GO:0046906 | |
| GeneOntologyMolecularFunction | iron ion binding | 2.35e-03 | 166 | 67 | 4 | GO:0005506 | |
| GeneOntologyMolecularFunction | calcium ion binding | 3.49e-03 | 749 | 67 | 8 | GO:0005509 | |
| GeneOntologyMolecularFunction | histone kinase activity | 3.96e-03 | 28 | 67 | 2 | GO:0035173 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 4.11e-03 | 194 | 67 | 4 | GO:0016705 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | 4.43e-03 | 614 | 67 | 7 | GO:0140657 | |
| GeneOntologyMolecularFunction | snoRNA binding | 5.81e-03 | 34 | 67 | 2 | GO:0030515 | |
| GeneOntologyMolecularFunction | oxygen binding | 6.85e-03 | 37 | 67 | 2 | GO:0019825 | |
| GeneOntologyMolecularFunction | actin filament binding | 7.13e-03 | 227 | 67 | 4 | GO:0051015 | |
| GeneOntologyBiologicalProcess | muscle filament sliding | 1.52e-07 | 15 | 69 | 4 | GO:0030049 | |
| GeneOntologyBiologicalProcess | heparan sulfate proteoglycan metabolic process | 2.64e-07 | 17 | 69 | 4 | GO:0030201 | |
| GeneOntologyBiologicalProcess | actin-myosin filament sliding | 3.39e-07 | 18 | 69 | 4 | GO:0033275 | |
| GeneOntologyBiologicalProcess | epoxygenase P450 pathway | 8.02e-07 | 22 | 69 | 4 | GO:0019373 | |
| GeneOntologyBiologicalProcess | proteoglycan metabolic process | 8.73e-07 | 97 | 69 | 6 | GO:0006029 | |
| GeneOntologyBiologicalProcess | heparan sulfate proteoglycan biosynthetic process | 5.55e-06 | 35 | 69 | 4 | GO:0015012 | |
| GeneOntologyBiologicalProcess | omega-hydroxylase P450 pathway | 1.27e-05 | 14 | 69 | 3 | GO:0097267 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 2.69e-05 | 105 | 69 | 5 | GO:0006721 | |
| GeneOntologyBiologicalProcess | linoleic acid metabolic process | 6.05e-05 | 23 | 69 | 3 | GO:0043651 | |
| GeneOntologyBiologicalProcess | arachidonate metabolic process | 7.95e-05 | 68 | 69 | 4 | GO:0019369 | |
| GeneOntologyBiologicalProcess | proteoglycan biosynthetic process | 8.90e-05 | 70 | 69 | 4 | GO:0030166 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 1.10e-04 | 141 | 69 | 5 | GO:0006805 | |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 1.21e-04 | 144 | 69 | 5 | GO:0006720 | |
| GeneOntologyBiologicalProcess | monoterpenoid metabolic process | 1.64e-04 | 6 | 69 | 2 | GO:0016098 | |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 2.57e-04 | 37 | 69 | 3 | GO:0042178 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 3.24e-04 | 40 | 69 | 3 | GO:0042573 | |
| GeneOntologyBiologicalProcess | olefinic compound metabolic process | 3.43e-04 | 180 | 69 | 5 | GO:0120254 | |
| GeneOntologyCellularComponent | muscle myosin complex | 2.04e-07 | 16 | 70 | 4 | GO:0005859 | |
| GeneOntologyCellularComponent | myosin filament | 1.38e-06 | 25 | 70 | 4 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 2.22e-06 | 28 | 70 | 4 | GO:0016460 | |
| GeneOntologyCellularComponent | myosin complex | 4.57e-05 | 59 | 70 | 4 | GO:0016459 | |
| Domain | Myosin_N | 2.39e-07 | 15 | 70 | 4 | PF02736 | |
| Domain | Myosin_N | 2.39e-07 | 15 | 70 | 4 | IPR004009 | |
| Domain | Myosin_tail_1 | 5.32e-07 | 18 | 70 | 4 | PF01576 | |
| Domain | Myosin_tail | 5.32e-07 | 18 | 70 | 4 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 6.72e-07 | 19 | 70 | 4 | IPR027401 | |
| Domain | - | 6.72e-07 | 19 | 70 | 4 | 4.10.270.10 | |
| Domain | PH_dom-like | 4.01e-06 | 426 | 70 | 10 | IPR011993 | |
| Domain | Myosin_head_motor_dom | 1.21e-05 | 38 | 70 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.21e-05 | 38 | 70 | 4 | PS51456 | |
| Domain | Myosin_head | 1.21e-05 | 38 | 70 | 4 | PF00063 | |
| Domain | MYSc | 1.21e-05 | 38 | 70 | 4 | SM00242 | |
| Domain | Cell_morpho_N | 1.38e-05 | 2 | 70 | 2 | IPR025614 | |
| Domain | MOR2-PAG1_mid | 1.38e-05 | 2 | 70 | 2 | IPR029473 | |
| Domain | MOR2-PAG1_mid | 1.38e-05 | 2 | 70 | 2 | PF14228 | |
| Domain | MOR2-PAG1_C | 1.38e-05 | 2 | 70 | 2 | PF14225 | |
| Domain | MOR2-PAG1_N | 1.38e-05 | 2 | 70 | 2 | PF14222 | |
| Domain | Cell_Morphogen_C | 1.38e-05 | 2 | 70 | 2 | IPR025481 | |
| Domain | Cyt_P450_E_grp-I | 2.40e-05 | 45 | 70 | 4 | IPR002401 | |
| Domain | Cyt_P450_CS | 4.61e-05 | 53 | 70 | 4 | IPR017972 | |
| Domain | CYTOCHROME_P450 | 6.15e-05 | 57 | 70 | 4 | PS00086 | |
| Domain | - | 6.59e-05 | 58 | 70 | 4 | 1.10.630.10 | |
| Domain | p450 | 6.59e-05 | 58 | 70 | 4 | PF00067 | |
| Domain | Cyt_P450 | 7.53e-05 | 60 | 70 | 4 | IPR001128 | |
| Domain | - | 1.04e-04 | 391 | 70 | 8 | 2.30.29.30 | |
| Domain | S100_CABP | 1.38e-04 | 27 | 70 | 3 | PS00303 | |
| Domain | S_100 | 1.38e-04 | 27 | 70 | 3 | PF01023 | |
| Domain | S100_Ca-bd_sub | 1.54e-04 | 28 | 70 | 3 | IPR013787 | |
| Domain | S100/CaBP-9k_CS | 1.54e-04 | 28 | 70 | 3 | IPR001751 | |
| Domain | S_100 | 1.54e-04 | 28 | 70 | 3 | SM01394 | |
| Domain | EF_hand_dom | 2.33e-04 | 232 | 70 | 6 | IPR002048 | |
| Domain | IQ | 2.42e-04 | 81 | 70 | 4 | SM00015 | |
| Domain | P-loop_NTPase | MYH2 MYH3 MYH6 MYH7 KIF23 SAMD9L DNM1L CHD8 HS3ST4 HS3ST3B1 HS3ST3A1 | 2.95e-04 | 848 | 70 | 11 | IPR027417 |
| Domain | Sulfotransferase_dom | 3.29e-04 | 36 | 70 | 3 | IPR000863 | |
| Domain | Sulfotransfer_1 | 3.29e-04 | 36 | 70 | 3 | PF00685 | |
| Domain | IQ_motif_EF-hand-BS | 3.63e-04 | 90 | 70 | 4 | IPR000048 | |
| Domain | IQ | 4.11e-04 | 93 | 70 | 4 | PS50096 | |
| Domain | - | 4.36e-04 | 261 | 70 | 6 | 1.10.238.10 | |
| Domain | EF_Hand_1_Ca_BS | 5.05e-04 | 175 | 70 | 5 | IPR018247 | |
| Domain | EF-hand-dom_pair | 7.19e-04 | 287 | 70 | 6 | IPR011992 | |
| Domain | Grip | 7.45e-04 | 11 | 70 | 2 | SM00755 | |
| Domain | GRIP | 7.45e-04 | 11 | 70 | 2 | PF01465 | |
| Domain | Ran_BP1 | 8.92e-04 | 12 | 70 | 2 | PF00638 | |
| Domain | GRIP_dom | 8.92e-04 | 12 | 70 | 2 | IPR000237 | |
| Domain | GRIP | 8.92e-04 | 12 | 70 | 2 | PS50913 | |
| Domain | RANBD1 | 8.92e-04 | 12 | 70 | 2 | PS50196 | |
| Domain | EF_HAND_1 | 1.01e-03 | 204 | 70 | 5 | PS00018 | |
| Domain | RanBD | 1.05e-03 | 13 | 70 | 2 | SM00160 | |
| Domain | Ran_bind_dom | 1.05e-03 | 13 | 70 | 2 | IPR000156 | |
| Domain | EF_HAND_2 | 1.75e-03 | 231 | 70 | 5 | PS50222 | |
| Domain | IQ | 2.40e-03 | 71 | 70 | 3 | PF00612 | |
| Domain | Ez/rad/moesin-like | 2.78e-03 | 21 | 70 | 2 | IPR000798 | |
| Domain | EFh | 2.93e-03 | 158 | 70 | 4 | SM00054 | |
| Domain | FERM_CS | 3.62e-03 | 24 | 70 | 2 | IPR019747 | |
| Domain | FERM_C | 4.25e-03 | 26 | 70 | 2 | PF09380 | |
| Domain | FERM_C | 4.57e-03 | 27 | 70 | 2 | SM01196 | |
| Domain | FERM_PH-like_C | 4.57e-03 | 27 | 70 | 2 | IPR018980 | |
| Domain | FERM_N | 6.78e-03 | 33 | 70 | 2 | PF09379 | |
| Domain | FERM_N | 6.78e-03 | 33 | 70 | 2 | IPR018979 | |
| Domain | EF-hand_8 | 7.19e-03 | 34 | 70 | 2 | PF13833 | |
| Pathway | REACTOME_XENOBIOTICS | 1.38e-06 | 23 | 52 | 4 | M5372 | |
| Pathway | REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET | 2.62e-06 | 8 | 52 | 3 | M27135 | |
| Pathway | KEGG_LINOLEIC_ACID_METABOLISM | 3.65e-06 | 29 | 52 | 4 | M2920 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 3.92e-06 | 9 | 52 | 3 | M27143 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 4.53e-06 | 183 | 52 | 7 | M39588 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 7.65e-06 | 11 | 52 | 3 | M27130 | |
| Pathway | WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID | 1.02e-05 | 12 | 52 | 3 | M48064 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES | 1.67e-05 | 14 | 52 | 3 | MM15842 | |
| Pathway | WP_TAMOXIFEN_METABOLISM | 6.01e-05 | 21 | 52 | 3 | M39631 | |
| Pathway | KEGG_GLYCOSAMINOGLYCAN_DEGRADATION | 6.01e-05 | 21 | 52 | 3 | M3624 | |
| Pathway | KEGG_ARACHIDONIC_ACID_METABOLISM | 6.03e-05 | 58 | 52 | 4 | M5410 | |
| Pathway | WP_OXIDATION_BY_CYTOCHROME_P450 | 7.84e-05 | 62 | 52 | 4 | M39653 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 8.88e-05 | 64 | 52 | 4 | M5650 | |
| Pathway | KEGG_RETINOL_METABOLISM | 8.88e-05 | 64 | 52 | 4 | M9488 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP5276 | 9.07e-05 | 24 | 52 | 3 | M46445 | |
| Pathway | REACTOME_XENOBIOTICS | 1.03e-04 | 25 | 52 | 3 | MM14846 | |
| Pathway | KEGG_TIGHT_JUNCTION | 1.22e-04 | 132 | 52 | 5 | M11355 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 1.26e-04 | 70 | 52 | 4 | M12294 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 1.26e-04 | 70 | 52 | 4 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 1.41e-04 | 72 | 52 | 4 | M9257 | |
| Pathway | REACTOME_HS_GAG_BIOSYNTHESIS | 1.62e-04 | 29 | 52 | 3 | MM14802 | |
| Pathway | REACTOME_HS_GAG_BIOSYNTHESIS | 1.98e-04 | 31 | 52 | 3 | M685 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESIN_LIKE_SPMS | 1.98e-04 | 6 | 52 | 2 | M27909 | |
| Pathway | WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE | 2.77e-04 | 7 | 52 | 2 | M39515 | |
| Pathway | REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET | 2.77e-04 | 7 | 52 | 2 | MM14856 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESINS | 3.68e-04 | 8 | 52 | 2 | M27891 | |
| Pathway | WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY | 4.73e-04 | 9 | 52 | 2 | M39819 | |
| Pathway | REACTOME_ASPIRIN_ADME | 5.64e-04 | 44 | 52 | 3 | M45014 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 5.77e-04 | 104 | 52 | 4 | M738 | |
| Pathway | REACTOME_DRUG_ADME | 6.88e-04 | 109 | 52 | 4 | M45012 | |
| Pathway | REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE | 7.19e-04 | 11 | 52 | 2 | MM14863 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 8.60e-04 | 12 | 52 | 2 | MM14847 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESINS | 8.60e-04 | 12 | 52 | 2 | MM15616 | |
| Pathway | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | 1.03e-03 | 54 | 52 | 3 | MM14633 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 1.08e-03 | 123 | 52 | 4 | MM14623 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 1.18e-03 | 126 | 52 | 4 | M695 | |
| Pathway | REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM | 1.20e-03 | 57 | 52 | 3 | M692 | |
| Pathway | REACTOME_ARACHIDONIC_ACID_METABOLISM | 1.33e-03 | 59 | 52 | 3 | M27140 | |
| Pathway | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | 1.84e-03 | 66 | 52 | 3 | MM14839 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS | 2.19e-03 | 19 | 52 | 2 | M27889 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS | 2.94e-03 | 22 | 52 | 2 | MM15614 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 3.15e-03 | 271 | 52 | 5 | MM15406 | |
| Pubmed | 1.50e-11 | 4 | 70 | 4 | 2009263 | ||
| Pubmed | 1.50e-11 | 4 | 70 | 4 | 21798861 | ||
| Pubmed | Biochemistry and molecular biology of the human CYP2C subfamily. | 1.50e-11 | 4 | 70 | 4 | 7704034 | |
| Pubmed | 1.50e-11 | 4 | 70 | 4 | 23755828 | ||
| Pubmed | 1.50e-11 | 4 | 70 | 4 | 19706858 | ||
| Pubmed | 5.24e-10 | 7 | 70 | 4 | 16819597 | ||
| Pubmed | 7.81e-09 | 3 | 70 | 3 | 28687336 | ||
| Pubmed | Myosin heavy chain gene expression in mouse embryoid bodies. An in vitro developmental study. | 7.81e-09 | 3 | 70 | 3 | 1939265 | |
| Pubmed | The human CYP2C locus: a prototype for intergenic and exon repetition splicing events. | 7.81e-09 | 3 | 70 | 3 | 10704292 | |
| Pubmed | A 2.4-megabase physical map spanning the CYP2C gene cluster on chromosome 10q24. | 7.81e-09 | 3 | 70 | 3 | 8530044 | |
| Pubmed | 7.81e-09 | 3 | 70 | 3 | 21173785 | ||
| Pubmed | Mouse embryonic stem cells express the cardiac myosin heavy chain genes during development in vitro. | 7.81e-09 | 3 | 70 | 3 | 1694848 | |
| Pubmed | 7.81e-09 | 3 | 70 | 3 | 15102943 | ||
| Pubmed | 7.81e-09 | 3 | 70 | 3 | 35134542 | ||
| Pubmed | 7.81e-09 | 3 | 70 | 3 | 24430292 | ||
| Pubmed | Distribution of CYP2C polymorphisms in an Amerindian population of Brazil. | 7.81e-09 | 3 | 70 | 3 | 21977947 | |
| Pubmed | 7.81e-09 | 3 | 70 | 3 | 20665013 | ||
| Pubmed | 7.81e-09 | 3 | 70 | 3 | 27803446 | ||
| Pubmed | Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population. | 7.81e-09 | 3 | 70 | 3 | 19954515 | |
| Pubmed | 7.81e-09 | 3 | 70 | 3 | 8095407 | ||
| Pubmed | 7.81e-09 | 3 | 70 | 3 | 23118231 | ||
| Pubmed | Novel DNA sequence variations of cytochrome P450 genes in the Han Chinese population. | 1.48e-08 | 14 | 70 | 4 | 19290787 | |
| Pubmed | Association of warfarin dose with genes involved in its action and metabolism. | 2.69e-08 | 16 | 70 | 4 | 17048007 | |
| Pubmed | 2.69e-08 | 16 | 70 | 4 | 9988767 | ||
| Pubmed | Polymorphism of CYP2D6, CYP2C19, CYP2C9 and CYP2C8 in the Faroese population. | 3.12e-08 | 4 | 70 | 3 | 16025294 | |
| Pubmed | 3.12e-08 | 4 | 70 | 3 | 28990182 | ||
| Pubmed | Molecular genetics of the human cytochrome P450 monooxygenase superfamily. | 7.11e-08 | 20 | 70 | 4 | 9890157 | |
| Pubmed | Prevalence of CYP450 gene variations in patients with type 2 diabetes. | 7.79e-08 | 5 | 70 | 3 | 20857895 | |
| Pubmed | 7.79e-08 | 5 | 70 | 3 | 19415824 | ||
| Pubmed | Developmental regulation of myosin gene expression in mouse cardiac muscle. | 7.79e-08 | 5 | 70 | 3 | 2277065 | |
| Pubmed | 1.55e-07 | 6 | 70 | 3 | 28381556 | ||
| Pubmed | A genome-wide association study of acenocoumarol maintenance dosage. | 1.55e-07 | 6 | 70 | 3 | 19578179 | |
| Pubmed | 1.55e-07 | 6 | 70 | 3 | 1728586 | ||
| Pubmed | Genetic polymorphism of cytochrome P450s and P-glycoprotein in the Finnish population. | 1.55e-07 | 6 | 70 | 3 | 17635176 | |
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 1.55e-07 | 6 | 70 | 3 | 10588881 | |
| Pubmed | 2.72e-07 | 7 | 70 | 3 | 35210422 | ||
| Pubmed | ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism. | 2.72e-07 | 7 | 70 | 3 | 29758057 | |
| Pubmed | 3.96e-07 | 30 | 70 | 4 | 20529763 | ||
| Pubmed | 4.34e-07 | 8 | 70 | 3 | 3864153 | ||
| Pubmed | 9.28e-07 | 10 | 70 | 3 | 19651758 | ||
| Pubmed | 9.28e-07 | 10 | 70 | 3 | 20602612 | ||
| Pubmed | 1.27e-06 | 11 | 70 | 3 | 15039299 | ||
| Pubmed | Genetic variation in eleven phase I drug metabolism genes in an ethnically diverse population. | 1.27e-06 | 11 | 70 | 3 | 15469410 | |
| Pubmed | Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers. | 1.27e-06 | 11 | 70 | 3 | 16024798 | |
| Pubmed | 1.27e-06 | 11 | 70 | 3 | 8341667 | ||
| Pubmed | The S100 family of EF-hand calcium-binding proteins: functions and pathology. | 1.70e-06 | 12 | 70 | 3 | 8701470 | |
| Pubmed | 1.70e-06 | 12 | 70 | 3 | 15319333 | ||
| Pubmed | Citalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations. | 1.70e-06 | 12 | 70 | 3 | 24528284 | |
| Pubmed | 1.71e-06 | 179 | 70 | 6 | 19074885 | ||
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 2.20e-06 | 13 | 70 | 3 | 8404542 | |
| Pubmed | 2.80e-06 | 14 | 70 | 3 | 24938781 | ||
| Pubmed | Stress-Induced Cyclin C Translocation Regulates Cardiac Mitochondrial Dynamics. | 2.80e-06 | 14 | 70 | 3 | 32248761 | |
| Pubmed | 2.80e-06 | 14 | 70 | 3 | 27184118 | ||
| Pubmed | 2.80e-06 | 14 | 70 | 3 | 20970553 | ||
| Pubmed | Six homeoproteins and a Iinc-RNA at the fast MYH locus lock fast myofiber terminal phenotype. | 3.49e-06 | 15 | 70 | 3 | 24852826 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 7574697 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 16198656 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 21526716 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 30562214 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 18480046 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 26122864 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 16367903 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 24288737 | ||
| Pubmed | [Association between genetic polymorphisms of CYP2C19 and CYP2C9 and phenytoin serum concentration]. | 3.99e-06 | 2 | 70 | 2 | 15569425 | |
| Pubmed | Multi-ethnic distribution of clinically relevant CYP2C genotypes and haplotypes. | 3.99e-06 | 2 | 70 | 2 | 22491019 | |
| Pubmed | Murine pulmonary myocardium: developmental analysis of cardiac gene expression. | 3.99e-06 | 2 | 70 | 2 | 7919499 | |
| Pubmed | Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms. | 3.99e-06 | 2 | 70 | 2 | 12435384 | |
| Pubmed | Important amino acid residues that confer CYP2C19 selective activity to CYP2C9. | 3.99e-06 | 2 | 70 | 2 | 18511451 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 28686288 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 18694831 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 20808793 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 34384224 | ||
| Pubmed | Developmental expression of human hepatic CYP2C9 and CYP2C19. | 3.99e-06 | 2 | 70 | 2 | 14634042 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 22918969 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 2726733 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 15606441 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 32567426 | ||
| Pubmed | CYP2C40, a unique arachidonic acid 16-hydroxylase, is the major CYP2C in murine intestinal tract. | 3.99e-06 | 2 | 70 | 2 | 10908295 | |
| Pubmed | Role of CYP2C9 and CYP2C19 polymorphisms in patients with atherosclerosis. | 3.99e-06 | 2 | 70 | 2 | 17868191 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 32868386 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 27617498 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 1847130 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 16873909 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 28513222 | ||
| Pubmed | Cytochromes P450 catalyze oxidation of alpha,beta-unsaturated aldehydes. | 3.99e-06 | 2 | 70 | 2 | 17599801 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 19038035 | ||
| Pubmed | Human cardiac myosin heavy chain gene mapped within chromosome region 14q11.2----q13. | 3.99e-06 | 2 | 70 | 2 | 2494889 | |
| Pubmed | Evidence that CYP2C19 is the major (S)-mephenytoin 4'-hydroxylase in humans. | 3.99e-06 | 2 | 70 | 2 | 8110777 | |
| Pubmed | Human cardiac myosin heavy chain genes and their linkage in the genome. | 3.99e-06 | 2 | 70 | 2 | 3037493 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 106274 | ||
| Pubmed | A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. | 3.99e-06 | 2 | 70 | 2 | 10520990 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 21778428 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 15385837 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 25518510 | ||
| Pubmed | Gene structure and upstream regulatory regions of human CYP2C9 and CYP2C18. | 3.99e-06 | 2 | 70 | 2 | 8333835 | |
| Pubmed | Structural organization of the human cardiac alpha-myosin heavy chain gene (MYH6). | 3.99e-06 | 2 | 70 | 2 | 8307559 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 29307555 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 16372821 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 15776277 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 15304505 | ||
| Interaction | CYP2C19 interactions | 3.82e-07 | 5 | 69 | 3 | int:CYP2C19 | |
| Interaction | HSPB8 interactions | 2.02e-06 | 172 | 69 | 7 | int:HSPB8 | |
| Interaction | CYP2C18 interactions | 2.08e-06 | 27 | 69 | 4 | int:CYP2C18 | |
| Interaction | TMEM260 interactions | 1.07e-05 | 13 | 69 | 3 | int:TMEM260 | |
| Interaction | FRY interactions | 2.08e-05 | 16 | 69 | 3 | int:FRY | |
| Interaction | FRYL interactions | 4.64e-05 | 58 | 69 | 4 | int:FRYL | |
| Interaction | SF3B6 interactions | 5.33e-05 | 194 | 69 | 6 | int:SF3B6 | |
| Interaction | PHEX interactions | 6.90e-05 | 4 | 69 | 2 | int:PHEX | |
| Interaction | PRKAG2 interactions | 8.69e-05 | 68 | 69 | 4 | int:PRKAG2 | |
| Interaction | SLC39A3 interactions | 9.73e-05 | 70 | 69 | 4 | int:SLC39A3 | |
| Interaction | CLK1 interactions | 1.04e-04 | 219 | 69 | 6 | int:CLK1 | |
| Interaction | B3GALT6 interactions | 1.18e-04 | 28 | 69 | 3 | int:B3GALT6 | |
| Interaction | AKIRIN2 interactions | 1.21e-04 | 74 | 69 | 4 | int:AKIRIN2 | |
| Interaction | LATS1 interactions | 1.26e-04 | 440 | 69 | 8 | int:LATS1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q23 | 1.27e-05 | 195 | 70 | 5 | chr10q23 | |
| Cytoband | 10q24 | 2.15e-05 | 35 | 70 | 3 | 10q24 | |
| Cytoband | 15q21-q22 | 3.42e-05 | 6 | 70 | 2 | 15q21-q22 | |
| Cytoband | 1q21 | 3.75e-04 | 91 | 70 | 3 | 1q21 | |
| Cytoband | 17p13.1 | 7.99e-04 | 118 | 70 | 3 | 17p13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr14q11 | 1.69e-03 | 332 | 70 | 4 | chr14q11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 1.97e-03 | 346 | 70 | 4 | chr17p13 | |
| Cytoband | 10p13 | 1.99e-03 | 43 | 70 | 2 | 10p13 | |
| Cytoband | 17p12 | 2.57e-03 | 49 | 70 | 2 | 17p12 | |
| Cytoband | 14q12 | 3.23e-03 | 55 | 70 | 2 | 14q12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | 3.43e-03 | 404 | 70 | 4 | chr1q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p12 | 4.35e-03 | 64 | 70 | 2 | chr17p12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q23 | 4.89e-03 | 68 | 70 | 2 | chr15q23 | |
| Cytoband | 2q13 | 4.89e-03 | 68 | 70 | 2 | 2q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q13 | 7.03e-03 | 82 | 70 | 2 | chr13q13 | |
| GeneFamily | Myosin heavy chains | 6.91e-08 | 15 | 50 | 4 | 1098 | |
| GeneFamily | Cytochrome P450 family 2 | 2.54e-06 | 35 | 50 | 4 | 1001 | |
| GeneFamily | S100 calcium binding proteins|EF-hand domain containing | 2.56e-05 | 21 | 50 | 3 | 459 | |
| GeneFamily | Sulfotransferases, membrane bound | 1.45e-04 | 37 | 50 | 3 | 763 | |
| GeneFamily | EF-hand domain containing | 3.39e-04 | 219 | 50 | 5 | 863 | |
| Coexpression | LEE_CALORIE_RESTRICTION_MUSCLE_UP | 5.32e-06 | 43 | 70 | 4 | MM669 | |
| Coexpression | SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN | 2.01e-05 | 20 | 70 | 3 | MM1104 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-07 | 159 | 70 | 6 | 5ca96db4281abb5f646150ccf36adc66ab201c78 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-07 | 161 | 70 | 6 | 1b805f77790aeb8a71b08bfac2fe2eed7343258f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.86e-07 | 170 | 70 | 6 | 876b84740e15399bfff2b9c7f0b80fd759bbdb3f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.86e-07 | 170 | 70 | 6 | 1f8738acf439d893880db7e1fdc9b3615ca00c39 | |
| ToppCell | severe-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.62e-07 | 177 | 70 | 6 | d1ad35ee3d2a84b1d01126d0a38464ab858c00d0 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_CTL|Control / Disease, condition lineage and cell class | 7.19e-07 | 199 | 70 | 6 | e8db312f392811ad79a43bf982fdb8c5805139bf | |
| ToppCell | COVID-19_Moderate-CD4+_CTL|World / disease group, cell group and cell class | 7.19e-07 | 199 | 70 | 6 | 12ea0346b4da3e8e2b3b2b3b3e9d4f4f104345a6 | |
| ToppCell | COVID-19_Moderate-CD4+_CTL|COVID-19_Moderate / disease group, cell group and cell class | 7.41e-07 | 200 | 70 | 6 | a9c73559e2c9fda1b065bfb5ce84978995505924 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rprm|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.09e-06 | 132 | 70 | 5 | 66ec5a06eece27c0aafb548f51db9fee595e71bc | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Gpr139|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.25e-06 | 134 | 70 | 5 | 917b8951dd4c870b6b92f2e73e02dac884330c30 | |
| ToppCell | TCGA-Bile_Duct|World / Sample_Type by Project: Shred V9 | 2.79e-06 | 140 | 70 | 5 | ca8a0ccbc2f501b759864fe9bb06dc8b44b6b31f | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.89e-06 | 141 | 70 | 5 | 5ef3166c5271aa90fd0633016edfe2c74b835319 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.92e-06 | 150 | 70 | 5 | 9d5bbdca19da60e1a2121ef64ec8e1375a5dbf6d | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.31e-06 | 153 | 70 | 5 | b37a1ecad389d2848b8ca4d287823e8048207420 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_ALM_Cpa6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.45e-06 | 154 | 70 | 5 | 12cbc38bc1f7231c67e1d2d5e86e95bc12e24682 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.05e-06 | 164 | 70 | 5 | f6a961fa2002da7d9679f32af99e1314c0593ef9 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.23e-06 | 165 | 70 | 5 | dbe231d00843cae917efd1abea6079ace3b45cdf | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.23e-06 | 165 | 70 | 5 | 9ccce713d4122054bf4bef4a7126d90cf9141b84 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.63e-06 | 172 | 70 | 5 | 08a3fe536b1b064c5ee7779bc2b1115a5963a26b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.63e-06 | 172 | 70 | 5 | 553701349444eb366df3c11f54bb093434f153c6 | |
| ToppCell | control-Lymphocytic-CD4_T_cells_3|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.84e-06 | 173 | 70 | 5 | 0c9fb18536ddd61b51b7bb4d40841f67b017f360 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-05 | 183 | 70 | 5 | 612d93df03252d4d2ccdce5a9bc162cfd9172a1a | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Artery|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.23e-05 | 190 | 70 | 5 | aed65d584ca0c25f6a8313c66b421a6618af82ea | |
| ToppCell | severe-Lymphocytic-CD4_T_cells_3|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.27e-05 | 191 | 70 | 5 | afff6bfae9a2f1e17d2731315e7fe63c4601679f | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD8-Trm/em_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.30e-05 | 192 | 70 | 5 | 7a122505d7adf236e0cbd9bcbc98e7c537600ca3 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_CTL|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.33e-05 | 193 | 70 | 5 | a4ba77be93d8786c41994eda97902fcd7381dd36 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_CTL-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.33e-05 | 193 | 70 | 5 | 5e59f0e4f3ec47d9cc7cf12d4c3732d6ee3a6923 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-CD8_low_T|normal_Lymph_Node / Location, Cell class and cell subclass | 1.33e-05 | 193 | 70 | 5 | e20ad6b62ad3aa386aa10b7a5d057d24a64ad386 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_CTL|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.33e-05 | 193 | 70 | 5 | 22ba8f27184c70ccab999d40904fe18abf99f190 | |
| ToppCell | Control-Lymphoid_T/NK-CD4+_CTL|Control / Disease group, lineage and cell class | 1.33e-05 | 193 | 70 | 5 | cf0bb9bedae054464a769b016e7b795a43675a24 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_CTL-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.33e-05 | 193 | 70 | 5 | 0143ef65087c644dd746eaa71c70d6c957577b0b | |
| ToppCell | COVID-19_Convalescent-CD4+_Tcm|COVID-19_Convalescent / Disease condition and Cell class | 1.43e-05 | 196 | 70 | 5 | f2a5eeb1cebde2762865ab29792370b751214c4d | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_DC-DC-DC3|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.43e-05 | 196 | 70 | 5 | d4e5b55a32d9c04c6b2ca7806a0d96231918761f | |
| ToppCell | Healthy_donor-CD4+_CTL|World / disease group, cell group and cell class (v2) | 1.47e-05 | 197 | 70 | 5 | 1dee9b905ef36e567acc1094a3c0e41f56d1261e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.51e-05 | 198 | 70 | 5 | a6b942fe850e287e1cb705684e29218072daf891 | |
| ToppCell | 10x5'-Liver-Myeloid_Monocytic|Liver / Manually curated celltypes from each tissue | 1.51e-05 | 198 | 70 | 5 | d0925948bf667545fb0b343e2fc80f7379e433e3 | |
| ToppCell | Caecum-T_cell-Treg|Caecum / Region, Cell class and subclass | 1.54e-05 | 199 | 70 | 5 | ab0b32c077ac26d32a293dcf686af6984980793f | |
| ToppCell | COVID-19_Moderate-CD8+_Tem|COVID-19_Moderate / disease group, cell group and cell class | 1.54e-05 | 199 | 70 | 5 | adcaf9bd73933259dcf7983ca369a98e2f312d0b | |
| ToppCell | 3'_v3-blood-Myeloid_Monocytic|blood / Manually curated celltypes from each tissue | 1.54e-05 | 199 | 70 | 5 | bf3a5085a5ae50f2ef745dce0a4ca8833b9438fd | |
| ToppCell | 10x5'-Liver-Myeloid_Monocytic-Classical_monocytes|Liver / Manually curated celltypes from each tissue | 1.54e-05 | 199 | 70 | 5 | 46491e8e76aa4d7ada036946f93cf71609c85462 | |
| ToppCell | Sigmoid-T_cell-Treg|Sigmoid / Region, Cell class and subclass | 1.54e-05 | 199 | 70 | 5 | 972f1306a38aab0ac9df97df67b28a38b6a05606 | |
| ToppCell | BAL-Control-cDC_0|Control / Compartment, Disease Groups and Clusters | 1.54e-05 | 199 | 70 | 5 | 4518ffa51ead9da1ddf07bf048b18602e50f0f84 | |
| ToppCell | Caecum-(1)_T_cell-(15)_Treg|Caecum / shred on region, Cell_type, and subtype | 1.54e-05 | 199 | 70 | 5 | 12c22b07a231c9dc548e9dc37e0a60296a4a6273 | |
| ToppCell | 3'_v3-blood-Myeloid_Monocytic-Classical_monocytes|blood / Manually curated celltypes from each tissue | 1.54e-05 | 199 | 70 | 5 | 95b27f4bf1300f885b95c1a70a54252274dc8f51 | |
| ToppCell | Sigmoid-(1)_T_cell-(15)_Treg|Sigmoid / shred on region, Cell_type, and subtype | 1.54e-05 | 199 | 70 | 5 | 0b736634aaac5759776cb8a0110b1f065b486b5f | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-CD4+_CTL|Multiple_Sclerosis / Disease, condition lineage and cell class | 1.58e-05 | 200 | 70 | 5 | 2e18ce20dc61ae90883139d1b0c29d145888c001 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-CD8+_T_activated|COVID-19_Severe / Disease, condition lineage and cell class | 1.58e-05 | 200 | 70 | 5 | b7f80b2db07119069fbf3d245cf1ad79e8648bab | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.58e-05 | 200 | 70 | 5 | 2bd8c35484fe6b0bc0f9314216786baaa97d1e95 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Artery|Control_saline / Treatment groups by lineage, cell group, cell type | 1.58e-05 | 200 | 70 | 5 | 65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rprm|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.85e-05 | 120 | 70 | 4 | 2b7596946f9268c4202348adf3069decd8313bb0 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 4.11e-05 | 122 | 70 | 4 | 37612ad087d9c11d4a3466244ab36224de31930b | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Mup5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.81e-05 | 127 | 70 | 4 | 6df92f80b8922ca00eb383f79cd8dda4d602adfc | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_ALM_Olfr111_Spon1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.81e-05 | 127 | 70 | 4 | cd69ba386796715e87674f8324d2acaad1d4d094 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6b-L6b_VISp_Col8a1_Rxfp1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.42e-05 | 131 | 70 | 4 | 81efe8b0ca4377e557a42ddb12aecaf3f46b15bf | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Nxph3|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.64e-05 | 138 | 70 | 4 | b63e26afafbd2cdeed9c9451e6f530ab6295504c | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6b|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.02e-05 | 140 | 70 | 4 | 17005ca714ba03d7528fe7979ffb4654a46b666c | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_4|367C / Donor, Lineage, Cell class and subclass (all cells) | 8.04e-05 | 145 | 70 | 4 | 29422c908d58081e6a748e362a7ac41bf001444c | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Krt80_Sla|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.41e-05 | 151 | 70 | 4 | f50c5ae9dae507df750df25e151b58685fec70ce | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.90e-05 | 153 | 70 | 4 | 0ef7c45cdd854c79e527006034029767f8e108b2 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 155 | 70 | 4 | c58a5fb8d853f12204e961d633e83452eb12a659 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 155 | 70 | 4 | 9cb8c42c2e451b2d4dcd7154a4b1bfd21bbb7ea8 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-04 | 156 | 70 | 4 | 4877aabf647238c0279e497345b6a6d5ee07ef9c | |
| ToppCell | 368C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.07e-04 | 156 | 70 | 4 | 1d681fa17e62815f5d5f90c86be3c248b38e011b | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 159 | 70 | 4 | d2de9391b00b6c47f5fe28a1bad6da2097107ee0 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 159 | 70 | 4 | da6b7f8039adc19839d6c090a0b3d68fb6445a79 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-04 | 160 | 70 | 4 | ec81814f3a475ba9bc049cb793bf93bc0b650d37 | |
| ToppCell | COVID-19_Severe-Treg|World / disease group, cell group and cell class | 1.21e-04 | 161 | 70 | 4 | c6eade2c60c572d823e6e81b5e8d47078671e9b0 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 162 | 70 | 4 | ed9ee98d6568b0ac2cd3af1d58a17364ff2cfa22 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.23e-04 | 162 | 70 | 4 | 6ffcf369d954c20ce036aa1d072cee4e205f728e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-Treg-Treg_6|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.23e-04 | 162 | 70 | 4 | bcbf7f80a2a1c80def795e345f16cf16e8b9d03b | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.26e-04 | 163 | 70 | 4 | 476e94e1d132eaaecb9e376bd32748a75ad22081 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D3|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.26e-04 | 163 | 70 | 4 | 8a4931c9fdaedcf6c319157821d3556cd25fc9e5 | |
| ToppCell | facs-GAT-Fat-24m-Lymphocytic-NK_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-04 | 163 | 70 | 4 | e58863a462cc504bced627f004a47890ee2307ce | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.29e-04 | 164 | 70 | 4 | e86899aa68aac572009618c7e017e6734b86357c | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-Activated_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.36e-04 | 166 | 70 | 4 | fb2cfbf1d0a0f1950dd24c08ba00ebd64b06ceb4 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.39e-04 | 167 | 70 | 4 | eed22d1a17aab84dacb1a488528bae9389644cb9 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.42e-04 | 168 | 70 | 4 | c09aa66fd1374ecc4b4d4b56600a6f04aafa5be9 | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC-cDC2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.42e-04 | 168 | 70 | 4 | 93b7138f17aa14a6398c9b4ea7237781a0e19a66 | |
| ToppCell | facs-BAT-Fat-24m-Lymphocytic-T_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.42e-04 | 168 | 70 | 4 | e268e9ee43a2cbf6153bcdf1e6e7674090ee2e6c | |
| ToppCell | E18.5-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.42e-04 | 168 | 70 | 4 | e393553208617a023f1646169c892a87c95db3f5 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_macrophage-stroma-osteoclast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.42e-04 | 168 | 70 | 4 | 1993e7fb6d7291d448219c813cb968ddad270bb5 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.45e-04 | 169 | 70 | 4 | 305cedbd97059029d7d2a248a8a4b6cfe281aa54 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Grp_(Neuron.Slc17a6.Grp)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.47e-04 | 65 | 70 | 3 | b7bc23af54d6d2f7afd584f4df42c24d7c49e344 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Grp_(Neuron.Slc17a6.Grp)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.47e-04 | 65 | 70 | 3 | 3b3630253f5713c4a688c74c4ea0f98c1fe42594 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.49e-04 | 170 | 70 | 4 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | COVID-19_Severe-Treg|COVID-19_Severe / disease group, cell group and cell class | 1.49e-04 | 170 | 70 | 4 | d61269a51283125835884c4aa50623756c4fdda2 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.49e-04 | 170 | 70 | 4 | b04e2f84024baaae9b4ff19bdac8c69afdb92a76 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-04 | 170 | 70 | 4 | 4a241e3c928f29dad179f723b3846991415dadc0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.49e-04 | 170 | 70 | 4 | 51dbfa07daf6f972b566f3f6abe7f46e080ec01c | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 171 | 70 | 4 | 355a27ea88410a84210f7e4298c7c4f90cf2f8a9 | |
| ToppCell | Control-Epithelial_cells-Airway_basal|Control / group, cell type (main and fine annotations) | 1.52e-04 | 171 | 70 | 4 | 3965ced4be6db14265a90673502fceee425837ca | |
| ToppCell | droplet-Liver-Npc-18m-Lymphocytic-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.52e-04 | 171 | 70 | 4 | 872b3b33cd3893d63c45617db0269692430b0e8b | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.52e-04 | 171 | 70 | 4 | 22ad6de44e1d3f72a3d78d46fd26a5743a4f84a5 | |
| ToppCell | facs-GAT-Fat-18m-Lymphocytic-T_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-04 | 172 | 70 | 4 | 17a486c5d0430abb133eab9f087e2ef8b60f7d25 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Granulocytic-Neutrophil|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.55e-04 | 172 | 70 | 4 | c32e6af9e2d29da47b5d870207b598cff11aef6c | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-04 | 172 | 70 | 4 | 381ae1c3c07d0a424f43455ec571653b192a946a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.55e-04 | 172 | 70 | 4 | 0b247fe57163af08132db8df42e6757699885295 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Granulocytic|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.55e-04 | 172 | 70 | 4 | 1a0556c97fcba126126c22adea5235d977d41ebe | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.59e-04 | 173 | 70 | 4 | 279efbab7810fa60ab12ea5d09a84800df4adef0 | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.62e-04 | 174 | 70 | 4 | e2f240d60bffbe8e6d60f0bb405b231bd3c96875 | |
| Computational | Cytochrome P450. | 3.69e-07 | 14 | 49 | 4 | MODULE_106 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 7.52e-05 | 50 | 49 | 4 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI_2 | |
| Computational | Genes in the cancer module 135. | 1.91e-04 | 25 | 49 | 3 | MODULE_135 | |
| Computational | Metal / Ca ion binding. | 3.31e-04 | 133 | 49 | 5 | MODULE_324 | |
| Computational | Genes in the cancer module 67. | 5.44e-04 | 227 | 49 | 6 | MODULE_67 | |
| Computational | Neighborhood of PTEN | 5.88e-04 | 85 | 49 | 4 | MORF_PTEN | |
| Drug | 4',5-dihydroxydiclofenac | 1.22e-09 | 6 | 70 | 4 | CID003052567 | |
| Drug | 3'-hydroxydiclofenac | 1.22e-09 | 6 | 70 | 4 | CID000112230 | |
| Drug | 5-hydroxydiclofenac | 3.98e-08 | 12 | 70 | 4 | CID003052566 | |
| Drug | 2'-(glutathion-S-yl)-deschlorodiclofenac | 1.09e-07 | 15 | 70 | 4 | ctd:C586542 | |
| Drug | fast white | 1.85e-07 | 42 | 70 | 5 | CID000024008 | |
| Drug | Azamulinum | 2.43e-07 | 18 | 70 | 4 | CID003086060 | |
| Drug | D 703 | 2.43e-07 | 18 | 70 | 4 | CID000054088 | |
| Drug | bufuralol | 2.77e-07 | 5 | 70 | 3 | ctd:C010831 | |
| Drug | hydroxytolbutamide | 3.07e-07 | 19 | 70 | 4 | CID000003656 | |
| Drug | 3C etc | 3.82e-07 | 20 | 70 | 4 | CID000164045 | |
| Drug | AC1L1BEQ | 4.19e-07 | 93 | 70 | 6 | CID000001407 | |
| Drug | nifedipine | MYH2 MYH3 MYH6 MYH7 CYP2C19 CYP2C8 CYP2C9 CYP2C18 BCO2 MYL10 | 5.44e-07 | 415 | 70 | 10 | CID000004485 |
| Drug | 4,4'-cyclohexylidenebisphenol | 5.53e-07 | 6 | 70 | 3 | ctd:C570106 | |
| Drug | AC1O5Z5L | 5.53e-07 | 6 | 70 | 3 | CID006443527 | |
| Drug | 3-hydroxymethylantipyrine | 6.94e-07 | 23 | 70 | 4 | CID000123963 | |
| Drug | purealin | 9.59e-07 | 58 | 70 | 5 | CID006419303 | |
| Drug | 5-fluorotryptamine | 9.66e-07 | 7 | 70 | 3 | ctd:C034536 | |
| Drug | 6-Fluoro-6-desoxyoxymorphone | 9.66e-07 | 7 | 70 | 3 | CID005486899 | |
| Drug | 16-O-demethylaconitine | 9.66e-07 | 7 | 70 | 3 | ctd:C486136 | |
| Drug | Tolbutamide | 9.87e-07 | 25 | 70 | 4 | ctd:D014044 | |
| Drug | 1,4-naphthoquinone | 1.16e-06 | 26 | 70 | 4 | ctd:C035342 | |
| Drug | 13-hydroxyeicosatetraenoic acid | 1.54e-06 | 8 | 70 | 3 | CID006439499 | |
| Drug | 11-HODE | 1.54e-06 | 8 | 70 | 3 | CID006438497 | |
| Drug | 5-bromotryptamine | 1.54e-06 | 8 | 70 | 3 | ctd:C040997 | |
| Drug | 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid | 1.54e-06 | 8 | 70 | 3 | ctd:C585955 | |
| Drug | blebbistatin | 1.54e-06 | 116 | 70 | 6 | CID003476986 | |
| Drug | (hydrochloride) | 1.84e-06 | 29 | 70 | 4 | CID000004923 | |
| Drug | triphenylstannanylium | 1.84e-06 | 29 | 70 | 4 | CID000091481 | |
| Drug | 5,6-epoxyeicosatrienoic acid | 2.13e-06 | 68 | 70 | 5 | CID000001778 | |
| Drug | 8(9)-EET | 2.29e-06 | 69 | 70 | 5 | CID000001901 | |
| Drug | 4,5-dihydropyrazole-1,5-dicarboxylic acid 1-((4-chlorophenyl)-amide) 5-(2-oxo-2H-(1,3')bipyridinyl-6'-yl)-amide | 2.31e-06 | 9 | 70 | 3 | ctd:C545880 | |
| Drug | Acenocoumarol | 2.31e-06 | 9 | 70 | 3 | ctd:D000074 | |
| Drug | 5-chlorotryptamine | 2.31e-06 | 9 | 70 | 3 | ctd:C529169 | |
| Drug | 3-(2-(4-(3-chloro-2-methylphenyl)1-piperazinyl)ethyl)5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazol dihydrochloride 3.5 hydrate | 2.31e-06 | 9 | 70 | 3 | ctd:C109602 | |
| Drug | 5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methylbenzoic acid | 2.31e-06 | 9 | 70 | 3 | ctd:C000588958 | |
| Drug | Tryptamines | 2.31e-06 | 9 | 70 | 3 | ctd:D014363 | |
| Drug | paliperidone | 2.42e-06 | 31 | 70 | 4 | CID000115237 | |
| Drug | BP-7,8-oxide | 2.76e-06 | 32 | 70 | 4 | CID000037455 | |
| Drug | sitaxsentan | 3.29e-06 | 10 | 70 | 3 | ctd:C106276 | |
| Drug | norketobemidone | 3.29e-06 | 10 | 70 | 3 | CID000161154 | |
| Drug | Haloperidol metabolite I | 4.51e-06 | 11 | 70 | 3 | CID000038282 | |
| Drug | trans-1,2-dihydro-1,2-naphthalenediol | 4.51e-06 | 11 | 70 | 3 | ctd:C507866 | |
| Drug | 4-(N-propionylanilino)piperidine | 6.00e-06 | 12 | 70 | 3 | CID000259381 | |
| Drug | carveol | 6.00e-06 | 12 | 70 | 3 | CID000007438 | |
| Drug | desethylamodiaquine | 6.00e-06 | 12 | 70 | 3 | ctd:C047386 | |
| Drug | norclozapine | 6.00e-06 | 12 | 70 | 3 | ctd:C058272 | |
| Drug | SM-2 | 7.22e-06 | 87 | 70 | 5 | CID000486033 | |
| Drug | furafylline | 7.61e-06 | 41 | 70 | 4 | CID000003433 | |
| Drug | AC1L18GM | 7.79e-06 | 13 | 70 | 3 | CID000000092 | |
| Drug | 7-hydroxyquinoline | 7.79e-06 | 13 | 70 | 3 | CID000011378 | |
| Drug | 1'-hydroxymidazolam | 7.79e-06 | 13 | 70 | 3 | CID000107917 | |
| Drug | clozapine N-oxide | 7.79e-06 | 13 | 70 | 3 | CID000036727 | |
| Drug | parathion | 9.00e-06 | 91 | 70 | 5 | CID000000991 | |
| Drug | dibenzylfluorescein | 9.32e-06 | 2 | 70 | 2 | ctd:C558664 | |
| Drug | 5-MeO-DIPT | 9.89e-06 | 14 | 70 | 3 | CID000151182 | |
| Drug | propionanilide | 9.89e-06 | 14 | 70 | 3 | CID000012107 | |
| Drug | sulfaphenazole | 1.01e-05 | 44 | 70 | 4 | CID000005335 | |
| Drug | polybrominated biphenyl | 1.01e-05 | 44 | 70 | 4 | CID000042948 | |
| Drug | carvedilol | 1.03e-05 | 161 | 70 | 6 | CID000002585 | |
| Drug | NSC9700 | HEXA MYH2 MYH3 MYH6 MYH7 CYP2C19 CYP2C8 CYP2C9 CYP2C18 CNTN3 | 1.04e-05 | 578 | 70 | 10 | CID000005408 |
| Drug | 4-hydroxymephenytoin | 1.23e-05 | 15 | 70 | 3 | CID000119507 | |
| Drug | Demecolcine | S100A2 CUL4A S100A4 FRY VPS13D SAMD9L PABPN1 MFSD6 UNC13C PRKDC PBXIP1 ARAP2 | 1.36e-05 | 878 | 70 | 12 | ctd:D003703 |
| Drug | S-(-)-Etomoxir | 1.43e-05 | 100 | 70 | 5 | CID000060765 | |
| Drug | omeprazole | 1.50e-05 | 101 | 70 | 5 | CID000004594 | |
| Drug | 4,4'-(hexafluoroisopropylidene)diphenol | 1.51e-05 | 16 | 70 | 3 | ctd:C571725 | |
| Drug | HCFC-141b | 1.51e-05 | 16 | 70 | 3 | CID000015586 | |
| Drug | Amodiaquine | 1.51e-05 | 16 | 70 | 3 | ctd:D000655 | |
| Drug | 6-hydroxychlorzoxazone | 1.51e-05 | 16 | 70 | 3 | CID000002734 | |
| Drug | 1-phenylazo-2-naphthol | 1.51e-05 | 16 | 70 | 3 | ctd:C024336 | |
| Drug | 1,1,1-trichloro-2-(4-hydroxyphenyl)-2-(4-methoxyphenyl)ethane | 1.51e-05 | 16 | 70 | 3 | ctd:C495657 | |
| Drug | 19-HETE | 1.56e-05 | 49 | 70 | 4 | CID006439528 | |
| Drug | 6-hydroxymelatonin | 1.70e-05 | 50 | 70 | 4 | CID000001864 | |
| Drug | diosmetin | 1.83e-05 | 17 | 70 | 3 | ctd:C039602 | |
| Drug | formycin triphosphate | 1.84e-05 | 51 | 70 | 4 | CID000122274 | |
| Drug | 7-benzyloxyquinoline | 2.20e-05 | 18 | 70 | 3 | CID003035604 | |
| Drug | pleuromutilin | 2.20e-05 | 18 | 70 | 3 | CID000031326 | |
| Drug | 2,4-oxazolidinedione | 2.20e-05 | 18 | 70 | 3 | CID000097389 | |
| Drug | triazolam | 2.31e-05 | 54 | 70 | 4 | CID000005556 | |
| Drug | phenacetin | 2.48e-05 | 55 | 70 | 4 | CID000004754 | |
| Drug | D 617 | 2.60e-05 | 19 | 70 | 3 | CID000093168 | |
| Drug | 6|A-Hydroxycortisol | 2.60e-05 | 19 | 70 | 3 | CID000150985 | |
| Drug | 5-(4-(3-(4-cyclohexyl-2-propylphenoxy)propoxy)phenyl)-1,3-oxazolidine-2,4-dione | 2.79e-05 | 3 | 70 | 2 | ctd:C502236 | |
| Drug | picoxystrobin | 2.79e-05 | 3 | 70 | 2 | ctd:C556557 | |
| Drug | 2-hydroxychlorpropamide | 2.79e-05 | 3 | 70 | 2 | CID003082454 | |
| Drug | Cyclohexenes | 2.79e-05 | 3 | 70 | 2 | ctd:D053138 | |
| Drug | mono-N-demethyladinazolam | 2.79e-05 | 3 | 70 | 2 | ctd:C050132 | |
| Drug | ortho-Aminobenzoates | 2.79e-05 | 3 | 70 | 2 | ctd:D062367 | |
| Drug | Delavirdine | 2.79e-05 | 3 | 70 | 2 | ctd:D020008 | |
| Drug | B0683 | 3.05e-05 | 117 | 70 | 5 | CID006398969 | |
| Drug | N'-nitrosoanatabine | 3.06e-05 | 20 | 70 | 3 | CID000051291 | |
| Drug | tamoxifen N-oxide | 3.06e-05 | 20 | 70 | 3 | CID003033895 | |
| Drug | 3-methoxymorphinan | 3.06e-05 | 20 | 70 | 3 | CID000001671 | |
| Drug | clevidipine | 3.06e-05 | 20 | 70 | 3 | CID000153994 | |
| Drug | 8-MOP | 3.18e-05 | 118 | 70 | 5 | CID000004114 | |
| Drug | Dicloxacillin sodium salt [13412-64-1]; Up 200; 8.2uM; PC3; HT_HG-U133A | 3.22e-05 | 197 | 70 | 6 | 6666_UP | |
| Drug | Dehydrocholic acid [81-23-2]; Down 200; 9.6uM; PC3; HG-U133A | 3.31e-05 | 198 | 70 | 6 | 1940_DN | |
| Drug | oxovanadium | 3.44e-05 | 120 | 70 | 5 | CID000024411 | |
| Drug | 1,1-dichloroethylene | 3.51e-05 | 60 | 70 | 4 | CID000006366 | |
| Drug | AC1L21VM | 3.56e-05 | 21 | 70 | 3 | CID000039524 | |
| Drug | nirvanol | 3.56e-05 | 21 | 70 | 3 | CID000091480 | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 5.36e-09 | 10 | 68 | 4 | DOID:0110454 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 5.36e-09 | 10 | 68 | 4 | DOID:0111269 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 5.36e-09 | 10 | 68 | 4 | DOID:0080719 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 5.36e-09 | 10 | 68 | 4 | DOID:0111602 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 5.36e-09 | 10 | 68 | 4 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 5.36e-09 | 10 | 68 | 4 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 5.36e-09 | 10 | 68 | 4 | DOID:0080326 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 5.36e-09 | 10 | 68 | 4 | DOID:0111596 (implicated_via_orthology) | |
| Disease | X-21258 measurement | 1.17e-08 | 3 | 68 | 3 | EFO_0800802 | |
| Disease | distal myopathy (implicated_via_orthology) | 1.26e-08 | 12 | 68 | 4 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.26e-08 | 12 | 68 | 4 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 1.82e-08 | 13 | 68 | 4 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 3.45e-08 | 15 | 68 | 4 | DOID:0050646 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 1.18e-06 | 80 | 68 | 5 | DOID:12930 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 4.65e-06 | 48 | 68 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | X-14473 measurement | 5.23e-06 | 2 | 68 | 2 | EFO_0021370 | |
| Disease | cyclo(leu-pro) measurement | 1.57e-05 | 3 | 68 | 2 | EFO_0800676 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 2.23e-05 | 71 | 68 | 4 | DOID:0050700 (implicated_via_orthology) | |
| Disease | Paroxysmal atrial fibrillation | 3.09e-05 | 156 | 68 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 3.09e-05 | 156 | 68 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 3.09e-05 | 156 | 68 | 5 | C2585653 | |
| Disease | Caveolinopathy | 3.13e-05 | 4 | 68 | 2 | cv:C5679790 | |
| Disease | CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1 | 3.13e-05 | 4 | 68 | 2 | 192600 | |
| Disease | protein S100-A4 measurement | 3.13e-05 | 4 | 68 | 2 | EFO_0021893 | |
| Disease | Cardiomyopathy, Familial Hypertrophic, 1 (disorder) | 3.13e-05 | 4 | 68 | 2 | C3495498 | |
| Disease | Hypertrophic cardiomyopathy 1 | 3.13e-05 | 4 | 68 | 2 | cv:C3495498 | |
| Disease | protein S100-A2 measurement | 3.13e-05 | 4 | 68 | 2 | EFO_0802961 | |
| Disease | Atrial Fibrillation | 3.48e-05 | 160 | 68 | 5 | C0004238 | |
| Disease | S-6-hydroxywarfarin to S-warfarin ratio measurement | 5.20e-05 | 88 | 68 | 4 | EFO_0803332 | |
| Disease | S-warfarin to R-warfarin ratio measurement | 7.01e-05 | 95 | 68 | 4 | EFO_0803331 | |
| Disease | Idiopathic hypertrophic subaortic stenosis | 1.09e-04 | 7 | 68 | 2 | C0700053 | |
| Disease | glycine conjugate of C10H14O2 (1) measurement | 1.09e-04 | 7 | 68 | 2 | EFO_0800655 | |
| Disease | Obstructive asymmetric septal hypertrophy | 1.09e-04 | 7 | 68 | 2 | C0597124 | |
| Disease | Cardiomyopathy, Hypertrophic, Familial | 1.86e-04 | 9 | 68 | 2 | C0949658 | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 1.86e-04 | 9 | 68 | 2 | EFO_0600040 | |
| Disease | Muscular dystrophy, limb-girdle, autosomal dominant | 2.33e-04 | 10 | 68 | 2 | cv:C5675009 | |
| Disease | ecosanoids measurement | 2.82e-04 | 55 | 68 | 3 | EFO_0020044 | |
| Disease | X-11308 measurement | 2.84e-04 | 11 | 68 | 2 | EFO_0800693 | |
| Disease | thymol sulfate measurement | 3.40e-04 | 12 | 68 | 2 | EFO_0021170 | |
| Disease | 16a-hydroxy DHEA 3-sulfate measurement | 5.39e-04 | 15 | 68 | 2 | EFO_0800301 | |
| Disease | andro steroid monosulfate C19H28O6S (1) measurement | 6.15e-04 | 16 | 68 | 2 | EFO_0800305 | |
| Disease | metabolonic lactone sulfate measurement | 8.72e-04 | 19 | 68 | 2 | EFO_0800659 | |
| Disease | peripheral arterial disease, traffic air pollution measurement | 1.06e-03 | 194 | 68 | 4 | EFO_0004265, EFO_0007908 | |
| Disease | Primary familial hypertrophic cardiomyopathy | 1.17e-03 | 22 | 68 | 2 | cv:C0949658 | |
| Disease | platelet reactivity measurement, response to clopidogrel | 1.28e-03 | 23 | 68 | 2 | EFO_0004985, GO_1903493 | |
| Disease | unipolar depression, response to selective serotonin reuptake inhibitor | 1.40e-03 | 24 | 68 | 2 | EFO_0003761, EFO_0005658 | |
| Disease | Hypertrophic obstructive cardiomyopathy | 1.52e-03 | 25 | 68 | 2 | C4551472 | |
| Disease | Limb-girdle muscular dystrophy | 1.64e-03 | 26 | 68 | 2 | cv:C0686353 | |
| Disease | atrial fibrillation | 1.67e-03 | 371 | 68 | 5 | EFO_0000275 | |
| Disease | Primary familial dilated cardiomyopathy | 2.18e-03 | 30 | 68 | 2 | cv:C0340427 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DKKTDESLTKYFHGF | 1836 | Q9HCK8 | |
| KKFHGYFKFQGQDTI | 131 | P36639 | |
| LKGHQKTDKNFFAYA | 1141 | Q96M83 | |
| GKFLHTKNKLYTDFD | 91 | O00429 | |
| LLVKYHSGFFVDGKF | 116 | P51813 | |
| HFLDKNGNFKKSDYF | 411 | P10632 | |
| GFLFLYKDVKSSKHD | 1466 | Q8WZ64 | |
| LAFGFGFSVKEFKDH | 396 | O60423 | |
| RGQSFKKNYAGIFHF | 161 | Q9UMQ6 | |
| KKEFFTKYQDHGFSE | 486 | Q9UMQ6 | |
| KFEFGKDKYNHWFDG | 91 | Q9BYV7 | |
| EGFQFGKKDLNFKGF | 981 | Q99666 | |
| EGFQFGKKDLNFKGF | 981 | O14715 | |
| NKTEKTEFLGFFYKH | 466 | Q6IN85 | |
| YKFGHTKVFFKAGLL | 756 | P12883 | |
| FDFKHYNKTLFAGLE | 506 | Q504Q3 | |
| ITDKHFYFNKTKGFP | 321 | Q9Y662 | |
| LGFDHKITGKQFYKQ | 251 | Q8N370 | |
| KFYRDGKFLHFSKEN | 51 | Q6DN72 | |
| GFKYLEYEKKHGSGD | 456 | Q9H1B7 | |
| QYKFGHTKVFFKAGL | 761 | Q9UKX2 | |
| FKHFKHKEGYSGTNT | 156 | O94915 | |
| YHFLRKFGSDKGVFS | 261 | Q7L591 | |
| ITDKHFYFNKTKGFP | 336 | Q9Y663 | |
| KATFHAFNKYKREGF | 716 | O75582 | |
| HAFKVFDTEGKGFVK | 161 | Q9BUA6 | |
| FFGKKGKAELNFEDF | 346 | Q86XE3 | |
| FRYNHFKNDDSKGKE | 391 | Q6ZSS7 | |
| YFSHFGDKQDKKIAP | 66 | P78552 | |
| FEGNHQFAKYKSFKV | 211 | O00602 | |
| DKFSGHPKGFAYIEF | 206 | Q86U42 | |
| SHFNLKEKEYFGIAF | 51 | Q9P2Q2 | |
| GYSSKFQFFPKHSEK | 156 | Q7Z6J6 | |
| AKVDKKLGRFFFSGY | 61 | P22748 | |
| HFLDEGGNFKKSNYF | 411 | P33261 | |
| FFKKHIQYKFLDEDF | 216 | O75794 | |
| GDKFIFNGEFKHKLF | 651 | Q13619 | |
| KNTFFEGLYEHGKDF | 171 | Q96RY5 | |
| HFLDKSGNFKKSDYF | 411 | P33260 | |
| NLAFKHFKYKEGYLG | 201 | Q5TBA9 | |
| HFLDEGGNFKKSKYF | 411 | P11712 | |
| YFNGALADFKKDGSH | 536 | Q9P232 | |
| VTEKHFYFNKTKGFP | 381 | Q9Y661 | |
| SKLTHLFKNYFDGEG | 391 | Q02241 | |
| KKGFGEDFKQLESFY | 341 | P06865 | |
| KTLKYFDHHGAGIFK | 381 | Q96DL1 | |
| FLEFKKSKEEHFYRG | 676 | Q8IVG5 | |
| KSKGKGFQHCVKYDF | 306 | Q8NFP9 | |
| FGYKNSKFHRVIKDF | 86 | P23284 | |
| FHKYSGKEGDKFKLN | 16 | P26447 | |
| QYKFGHTKVFFKAGL | 756 | P11055 | |
| ASFVFGEKYKDHFFA | 271 | Q9HAS3 | |
| GEKYKDHFFAFKVLP | 276 | Q9HAS3 | |
| GGFLAQKFAEYTHKS | 111 | Q9NZD8 | |
| NQYKFGHTKVFFKAG | 756 | P13533 | |
| FHKFAGDKGYLTKED | 16 | P60903 | |
| GENLYKFEEHGKAFN | 576 | Q9UII5 | |
| YGKELFDKANKHHFL | 36 | Q8N2U0 | |
| KQYFHAGGNGLKKNF | 1986 | Q8NB66 | |
| FVHKENGFTYFYKGK | 491 | P51512 | |
| DFIFSHFFGDKALKK | 686 | Q96AQ6 | |
| GKKRGFGFVYFQNHD | 136 | Q13151 | |
| EFTHGFDNNGRKYDK | 581 | P78562 | |
| KFIQTFGKEFDKHFG | 3631 | P78527 | |
| FIGAYFGFKKNAIEH | 486 | Q99805 | |
| TFHKYSCQEGDKFKL | 16 | P29034 | |
| KGFKHFLVDASGDFY | 366 | Q5SQS7 | |
| KFFDLFEKCDGYKSG | 406 | O43314 | |
| NGIKEKHGFDYAKDY | 176 | Q8IWU6 | |
| QGYLEKKSKDHSFFG | 111 | Q86WV1 | |
| FGLKHFDNYFGCKFL | 151 | Q8NFZ6 | |
| ADFFYKGKVHTSGFG | 646 | Q5THJ4 |